Michael D. Liang
Impact in
- Immunology top 10%
- Immune Response and Inflammation
- Immune cells in cancer
- Oncology top 10%
- Colorectal Cancer Treatments and Studies
- Neutropenia and Cancer Infections
- Lung Cancer Research Studies
- Cancer Treatment and Pharmacology
Papers in
-
- Cancer therapeutics and mechanisms 5
- Oncology 7
- Neutropenia and Cancer Infections 5
- Cancer Treatment and Pharmacology 4
- Cytokine Signaling Pathways and Interactions 1
- Co-authors
- Matthew J. Fenton (3 shared papers)Sylvia Marecki (2 shared papers)Jean L. Grem (6 shared papers)Natalia Cuesta (1 shared paper)Chris H. Takimoto (6 shared papers)Kurt A. Heldwein (1 shared paper)Stefanie N. Vogel (1 shared paper)Karen E. Thomas (1 shared paper)
- Journals
- Journal of Clinical Oncology (2 papers)Cancer Chemotherapy and Pharmacology (2 papers)The Journal of Immunology (1 paper)Journal of Leukocyte Biology (1 paper)Journal of Biological Chemistry (1 paper)
- Partner nations
- United StatesUkraineMalaysia
In The Last Decade
Michael D. Liang
10 papers receiving 658 citations
Peers
Comparison fields: 5 of 79
- Immunology 292
- Oncology 268
- Infectious Diseases 76
- Microbiology 25
- Molecular Biology 261
Countries citing papers authored by Michael D. Liang
This map shows the geographic impact of Michael D. Liang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Michael D. Liang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Michael D. Liang more than expected).
Fields of papers citing papers by Michael D. Liang
This network shows the impact of papers produced by Michael D. Liang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Michael D. Liang. The network helps show where Michael D. Liang may publish in the future.
Co-authors
The 25 scholars most cited alongside Michael D. Liang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2003 | 179 | |
| 2 | Severe neurotoxicity following 5-fluorouracil-based chemotherapy in a patient with dihydropyrimidine dehydrogenase deficiency. | 1996 | 133 |
| 3 | 2001 | 98 | |
| 4 | 2005 | 86 | |
| 5 | 1996 | 61 | |
| 6 | 2006 | 48 | |
| 7 | 1997 | 39 | |
| 8 | 2001 | 11 | |
| 9 | 2003 | 8 | |
| 10 | 1996 | 4 |
About Michael D. Liang
Michael D. Liang is a scholar working on Molecular Biology, Oncology, Immunology, Pharmacology and Infectious Diseases, having authored 10 papers that have together received 667 indexed citations. Recurring topics across this work include Cancer therapeutics and mechanisms (5 papers), Neutropenia and Cancer Infections (5 papers), Cancer Treatment and Pharmacology (4 papers), Immune Response and Inflammation (4 papers), Antibiotics Pharmacokinetics and Efficacy (2 papers), Immune Cell Function and Interaction (2 papers), NF-κB Signaling Pathways (1 paper) and Cytokine Signaling Pathways and Interactions (1 paper). The work is most often cited by research in Immunology (292 citations), Oncology (268 citations), Infectious Diseases (76 citations), Microbiology (25 citations) and Molecular Biology (261 citations). Michael D. Liang has collaborated with scholars based in United States, Ukraine and Malaysia. Frequent co-authors include Matthew J. Fenton, Sylvia Marecki, Jean L. Grem, Natalia Cuesta, Chris H. Takimoto, Kurt A. Heldwein, Stefanie N. Vogel, Karen E. Thomas, Aileen M. Marty and Carmen J. Allegra. Their work appears in journals such as Journal of Clinical Oncology, Cancer Chemotherapy and Pharmacology, The Journal of Immunology, Journal of Leukocyte Biology and Journal of Biological Chemistry.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.